AMD responded to new needs in diabetology by developing a paper that addresses two aspects of the problem: the personalization of therapy, and therapeutic pathways aimed at rendering this approach useable (customized treatment pathways). Seven algorithms to manage patients with type 2 diabetes and comorbidities.
Fai una donazione
